MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.immuni.2026.05.012

Медицинская библиотека · Immunity · 2026

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Williams Barnabas G, Barrett Jordan R, Scott Josefin Bartholdson, Rigby Cassandra A, Cagiada Matteo, Quinkert Doris, McHugh Kirsty, Huhn Anna, Burnap Sean A, Gourjault Camille, Byrne Francesca, Raghavan Sai Sundar Rajan, Rodrigues Ana, Bergamaschi Laura, Balzarotti Beatrice, Watson Simon, Miller Noah, King Lloyd D W, Donnellan Francesca R, Gladstone Camilla A, Paterson Jemima, Scalabrino Stefania, Silk Sarah E, Salkeld Jo, Minassian Angela M, Skinner Katherine, Struwe Weston B, Deane Charlotte M, Reece Stephen T, Ward Andrew B, Draper Simon J

СтатьяПеревод в очереди

Аннотация

Plasmodium falciparum RH5-interacting protein (RIPR) is central to the essential PTRAMP-CSS-RIPR-CyRPA-RH5 (PCRCR) complex, a leading target of blood-stage malaria vaccines. However, mechanisms whereby anti-RIPR antibodies inhibit parasite invasion are poorly understood. We characterized 83 human IgG monoclonal antibodies (mAbs) from RIPR-vaccinated Kymouse platform mice. Single mAbs had minimal neutralizing activity; however, high-level synergistic inhibition was observed with pools of mAbs targeting the RIPR-tail region. Structural characterization and molecular dynamics simulations of RIPR-tail showed that mAbs targeting epidermal growth factor (EGF)-like domains 6-8 (RIPREGF (6-8)), but not RIPREGF (9-10) or the C-terminal domain (RIPRCTD), synergized to constrain the RIPR-tail conformation. The same antibodies dissociated PTRAMP-CSS from RIPR, thereby enabling anti-RIPREGF (9-10)-CTD mAbs or anti-CSS single-domain Abs to bind and potentiate anti-RIPREGF (6-8) IgG. Addition of these mAbs to IgG from humans immunized with the R78C (RIPREGF (7-8)-CyRPA) candidate vaccine enhanced malaria growth inhibition. These data provide a framework to guide next-generation blood-stage malaria vaccine design.

Для цитирования: Williams Barnabas G, Barrett Jordan R, Scott Josefin Bartholdson, Rigby Cassandra A, Cagiada Matteo, Quinkert Doris, McHugh Kirsty, Huhn Anna, Burnap Sean A, Gourjault Camille, Byrne Francesca, Raghavan Sai Sundar Rajan, Rodrigues Ana, Bergamaschi Laura, Balzarotti Beatrice, Watson Simon, Miller Noah, King Lloyd D W, Donnellan Francesca R, Gladstone Camilla A, Paterson Jemima, Scalabrino Stefania, Silk Sarah E, Salkeld Jo, Minassian Angela M, Skinner Katherine, Struwe Weston B, Deane Charlotte M, Reece Stephen T, Ward Andrew B, Draper Simon J. Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.. Immunity. 2026. DOI: 10.1016/j.immuni.2026.05.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.